Trials / Active Not Recruiting
Active Not RecruitingNCT06174779
A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
A Multicenter, Randomized, Double-blind, Phase 3 Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 420 (estimated)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, randomized, double-blind, phase 3 study to evaluate efficacy and safety of HM11260C in adult obesity patients without diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HM11260C | Test drug |
| DRUG | Placebo | Placebo drug |
Timeline
- Start date
- 2024-01-03
- Primary completion
- 2025-12-31
- Completion
- 2026-07-31
- First posted
- 2023-12-18
- Last updated
- 2025-06-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06174779. Inclusion in this directory is not an endorsement.